Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
|2||Not yet recruiting||
A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis
Adherence in Pediatric Multiple Sclerosis
Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)
Safety and Efficacy in Pediatric MS Patients Prescribed Tysabri
DTI in Children With Multiple Sclerosis
† Study has passed its completion date and status has not been verified in more than two years.